Malta - engelsk - Medicines Authority

ethypharm 194 bureaux de la colline, bâtiment d, 92213 saint-cloud cedex, france - adrenaline, sodium - solution for injection in a pre-filled syringe - adrenaline 0.1 mg/ml sodium 0.117 mmol/ml - cardiac therapy

Malta - engelsk - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - adrenaline - solution for injection - adrenaline 1 mg/ml - cardiac therapy

Malta - engelsk - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - adrenaline - injection - adrenaline 1 mg/ml - cardiac therapy

Malta - engelsk - Medicines Authority

health house pharma ltd t/as p&d pharmaceuticals ltd 38 woolmer way, bordon, hampshire, gu35 9q, united kingdom - adrenaline - solution for injection in a pre-filled syringe - adrenaline 0.1 mg/ml - cardiac therapy

Malta - engelsk - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - adrenaline - solution for injection - adrenaline 1 mg/ml - cardiac therapy

Malta - engelsk - Medicines Authority

associated equipment ltd 11, lourdes square, rihan avenue, san gwann, , malta - adrenaline - solution for injection in a pre-filled syringe - adrenaline 0.5 mg/5ml - cardiac therapy

Malta - engelsk - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - adrenaline - solution for injection - adrenaline 1 mg - cardiac therapy

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium metabisulfite; sodium hydroxide; sodium chloride - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 5 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium metabisulfite; hydrochloric acid; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty microgram/ml) - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.